Informations générales (source: ClinicalTrials.gov)
Assessment of HGI (Hemoglobin Glycation Index) Variability Over Time in Patients Living With Diabetes Using Continuous Glucose Monitoring
Interventional
N/A
Nantes University Hospital (Voir sur ClinicalTrials)
juin 2024
septembre 2028
02 décembre 2025
The goal of this clinical trial is to learn about the variability of HGI (Hemoglobin
Glycation Index) over time in patients living with diabetes using a continuous glucose
monitoring.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL NOVO | CAMPINOS Catherine | 18/09/2025 17:50:07 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| HOPITAL NOVO | Catherine CAMPINOS | Contact (sur clinicalTrials) | |||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHU de Nantes - 44093 - Nantes 2990969 - France | Hélène AUFFRET | Contact (sur clinicalTrials) | |||
| CHU de Poitiers - 86021 - Poitiers 2986495 - France | Xavier PIGUEL | Contact (sur clinicalTrials) | |||
| CHU de Rennes - 35000 - Rennes 2983990 - France | Agathe GUENEGO | Contact (sur clinicalTrials) | |||
| CHU de Toulouse - 31059 - Toulouse 2972315 - France | Pierre GOURDY | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CH de La Rochelle - 17019 - La Rochelle 3006787 - France | Didier GOUET | Contact (sur clinicalTrials) | |||
| CH du Mans - 72037 - Le Mans 3003603 - France | Charly VAILLANT | Contact (sur clinicalTrials) | |||
| CHU d'Angers - 49100 - Angers 3037656 - France | Claire BRIET | Contact (sur clinicalTrials) | |||
| CHU de Brest - 29200 - Brest 3030300 - France | Philippe THUILLIER | Contact (sur clinicalTrials) | |||
| CHU de Caen - 14033 - Caen 3029241 - France | Michael JOUBERT | Contact (sur clinicalTrials) | |||
Critères
Tous
- Major (adult subject over 18), with no upper age limit
- Enrolled in a social security scheme or beneficiary of such a scheme
- Agreement to participate (informed, written consent)
- Established diabetes (regardless the type of diabetes), known for at least 6 months
at inclusion
- Regular user of a glucose monitoring system for at least 3 months.
Non inclusion Criteria:
- Known hemoglobinopathy
- Inadequate use of the flash glucose monitoring system with a capture rate of less
than 70% of interstitial glucose measurements, during the 3 months preceding the
inclusion visit.
- Stage 5 renal insufficiency (CKD-EPI less than 15 mL/min/1.73 m2)
- Pregnant or breast-feeding
- Major under guardianship, curatorship or safeguard of justice
- Any situation assessed by the investigator as potentially prejudicial to the
participant's health as a result of participation in the study
Exclusion criteria:
- Treatment with corticosteroids in the 3 months preceding the visit
- Unusual acute situation (infection, very unusual physical activity, etc.) deemed
significant by the investigator
- Pregnancy started